Reading the market regime before prices move
Reading the market regime before prices move
Every number here is computed from the traded ELV options chain. The call wall is where dealer hedging accumulates above spot and caps upside, the put wall is its mirror below, and the gamma flip is the level where hedging stops damping moves and starts amplifying them.
Computed
Earnings Oct 21, 2026 before the open · the market prices a ±6.05% move ($407.87 to $460.39) · its median actual move over the last 16 reports was ±3.38%.
Last completed session, from the Finviro engine close archive · today's session levels refresh every five minutes inside the platform.
Price moves between these levels whether you see them or not. The difference is knowing them before your decision, not after.
You can check SPY, QQQ, NVDA in full right now, with no subscription.
Elevance Health Inc. is a company in the Healthcare sector, listed on the New York Stock Exchange since 2001, with a market value of about $83.8B. It is led by Gail Koziara Boudreaux and has about 96,615 employees.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical,…
Its beta is 0.70: the stock is usually calmer than the broad market, so its moves are narrower than the index.
On the price was $434.13, above its 50-day simple average (DMA-50 at $405.41) by 7.1%, and above its 200-day average (DMA-200 at $370.05) by 17%. Price is above both averages: the medium- and long-term trend is up.
Revenue was $199.13B in fiscal year 2025, against $138.64B in 2021, a change of +44% over 4 years.
Out of every $100 of revenue, about $3 is left as net income after all costs and taxes, so the net margin is 2.8%.
The operating margin is 3.6%: what is left of revenue after operating costs, before interest and taxes.
Earnings per share were $25.28 in 2025, against $25.04 in 2021.
Free cash flow was $3.17B: the cash left after spending on operations and investment, which funds dividends and buybacks.
Debt to equity is 1.77: the higher it is, the more the company relies on borrowing.
These numbers describe the company's size and profitability and change slowly, while gamma levels describe how the stock moves within the session.
